Our findings highlight Rai/Akt/GSK-3 axis in the control of PD-1 expression and Rai expression levels in TILs of CRC patients as a potential new biomarker of T cell exhaustion and a predictive biomarker for anti-PD-1 response. This evidence concerns the gene SHC3 and colorectal carcinoma.